Epstein Secrets

iew & sales forecast missed estimates (trading -6%) • Nike Q4 profit up 22% beating estimates as sales jumped in US (guidance ok) (trading -2%) • Pfizer boosts share buyback by $10 Billion (keeps repurchase strategy as best use of cash) • Adobe to buy privately held Neolane (digital marketing compan

res priced at $18, Silvercrest Asset Management (SAMG) 4.79M shares priced at $11 IPO's: IBEX LN, MATAS DC, KGX GY, Ocean Yield books closing today US Key Research: ••• Jefferies initiates OCN/PMT/WAC (buys) & NSM/PFSI/PHH (holds), Roth re-establishes BDE (neut) •••• Opco initiates ZINC (op) & PANW/HXL (perfor

e year (and sixth worst day ever) closing -11.6% with talk of margin calls as newly listed PeptiDream fell 28% due to a cancellation of a pact with Pfizer. After the Australian close, Kevin Rudd announced he would accept the challenge of his successor Julia Gillard to stand for Labor leadership, with b

4M shares priced at $10 (below), Green REIT plc IPO launch (€200M+ thru JPM & Davy, pricing July 12) IPO's (lock-up expires): Tumi Holdings (TUMI) US Key Research: ••• Barcap reinstates NDAQ (ow), Citi downgrades MOSNHS, DB initiates ADS (buy) ••• Jefferies upgrades ADBE (buy), JPM upgrades BSAC & downgrades

, RTN, SSH, STML Shareholder Meetings: ATK, CA, ENV, MCK, GNMT, EA Equity/Mixed Shelfs: EQR Other Newspaper Articles & Stories Barron's positive: Pfizer (PFE) WSJ WSJ negative: Outlook for potash WSJ WSJ positive: Barclays (BARC LN) WSJ EFTA00386265 • Manning found not guilty of aiding enemy FT

s missed QCOR sales gained — RVBD sees eps/revs below — SIMG topped Secondaries (announced/priced): NLCH, TRS, STNG, BCRX, CUZ, FER SM IPO's: N/A US Key Research: ••• Atlantic downgrades XYL, Jefferies downgrades OPTR, Wells cuts NVDA/ROK & upgrades TVL ••• BMO cuts DCI, RBC upgrades GGP, SunTrust initiates